Leonhard Müllauer
Impact in
- Genetics top 0.2%
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Hematology top 0.5%
- Acute Myeloid Leukemia Research
- Chronic Myeloid Leukemia Treatments
Papers in
- Genetics 47
- Myeloproliferative Neoplasms: Diagnosis and Treatment 23
-
- Lymphoma Diagnosis and Treatment 30
- Co-authors
- Markus Raderer (34 shared papers)Peter Valent (35 shared papers)Andreas Chott (16 shared papers)Berthold Streubel (14 shared papers)Wolfgang R. Sperr (21 shared papers)Ingrid Simonitsch‐Klupp (15 shared papers)Felicitas Oberndorfer (8 shared papers)Christoph Carl Zielinski (10 shared papers)
- Journals
- Blood (14 papers)Annals of Hematology (9 papers)Journal of Personalized Medicine (9 papers)Oncotarget (8 papers)Cancers (8 papers)
- Partner nations
- AustriaGermanyUnited States
In The Last Decade
Leonhard Müllauer
223 papers receiving 7.8k citations
Leonhard Müllauer's Hit Papers
Peers
Comparison fields: 5 of 121
- Genetics 2.5k
- Hematology 1.7k
- Pathology and Forensic Medicine 1.4k
- Rheumatology 1.0k
- Immunology 1.3k
Countries citing papers authored by Leonhard Müllauer
This map shows the geographic impact of Leonhard Müllauer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leonhard Müllauer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leonhard Müllauer more than expected).
Fields of papers citing papers by Leonhard Müllauer
This network shows the impact of papers produced by Leonhard Müllauer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leonhard Müllauer. The network helps show where Leonhard Müllauer may publish in the future.
Co-authors
The 25 scholars most cited alongside Leonhard Müllauer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 228 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Survival and prognosis among 1545 patients with contemporary polycythemia vera: an international study Hit paper breakdown → | 2013 | 543 |
| 2 | 2011 | 404 | |
| 3 | 2004 | 312 | |
| 4 | 2012 | 214 | |
| 5 | 2012 | 178 | |
| 6 | Gelsolin: a candidate for suppressor of human bladder cancer. | 1995 | 171 |
| 7 | 2008 | 148 | |
| 8 | 2011 | 141 | |
| 9 | 2021 | 139 | |
| 10 | 2017 | 136 | |
| 11 | 2012 | 133 | |
| 12 | 2001 | 132 | |
| 13 | 1997 | 131 | |
| 14 | 2013 | 123 | |
| 15 | 2017 | 114 | |
| 16 | 2010 | 113 | |
| 17 | 2006 | 110 | |
| 18 | 2017 | 108 | |
| 19 | 2013 | 107 | |
| 20 | 2008 | 102 |
About Leonhard Müllauer
Leonhard Müllauer is a scholar working on Genetics, Pathology and Forensic Medicine, Oncology, Immunology and Hematology, having authored 228 papers that have together received 8.0k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (30 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (23 papers), Mast cells and histamine (22 papers), Cancer Genomics and Diagnostics (21 papers), Eosinophilic Disorders and Syndromes (19 papers), Lung Cancer Treatments and Mutations (15 papers), Acute Myeloid Leukemia Research (15 papers) and Myasthenia Gravis and Thymoma (12 papers). The work is most often cited by research in Genetics (2.5k citations), Hematology (1.7k citations), Pathology and Forensic Medicine (1.4k citations), Rheumatology (1.0k citations) and Immunology (1.3k citations). Leonhard Müllauer has collaborated with scholars based in Austria, Germany and United States. Frequent co-authors include Markus Raderer, Peter Valent, Andreas Chott, Berthold Streubel, Wolfgang R. Sperr, Ingrid Simonitsch‐Klupp, Felicitas Oberndorfer, Christoph Carl Zielinski, Julius Lukas and Heinz Gisslinger. Their work appears in journals such as Blood, Annals of Hematology, Journal of Personalized Medicine, Oncotarget and Cancers.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.